Dr. Little is Senior Research Scholar at the Kennedy Institute of Ethics, and Professor of Philosophy at Georgetown. Her research interests include issues in reproduction, clinical research ethics, data ethics, and the structure of moral theory.
A Rhodes Scholar and fellow of the Hastings Center, she has twice served as Visiting Scholar in residence at the National Institutes of Health Department of Bioethics, and was appointed to the Ethics Committee of the American College of Obstetrics and Gynecology. She is co-founder of The Second Wave Initiative, which works to promote responsible research into the health needs of pregnant women.
In her previous role as Director of the Kennedy Institute, Dr. Little oversaw a time of transformative development, including the launch of the world’s first Introduction to Bioethics MOOC in April 2014; the inauguration of Conversations in Bioethics , an annual campus-wide event focused on a critical issue in bioethics; the deployment of a series of experimental undergraduate courses utilizing project-based learning and design studio methods. Dr. Little is founder and Director of EthicsLab , a unique team of Philosophers and Designers at Georgetown University that develops new methods to help people build ethical frameworks to better address real-world problems. Ethics Lab works to help surface the moral values at stake in emerging, complex issues, including data ethics and AI, to help build responsible progress. She is a founding co-chair of the Tech and Society Initiative at Georgetown.
James Giordano and Maggie Little were part of the faculty teaching the Intensive Bioethics Course (IBC) 44, which took place at Georgetown University on June 9-11, 2022.…
Maggie Little and her co-authors describe the process, ethical foundations, recommendations and applications of guidance for advancing responsible inclusion of pregnant people in HIV/co-infections research.…
Maggie Little moderated a panel on approaches to managing trustworthy AI as part of the National Institute of Standards and Technology’s Artificial Intelligence Risk Management Framework workshop.…
Maggie Little and James Giordano spoke at the Kennedy Institute of Ethics 50th Anniversary Symposium on Bioethics, with the theme of “A New Era of Bioethics At Georgetown”. The symposium was held in Georgetown University, in association with the Pellegrino Center for Clinical Bioethics, which celebrated its 30th anniversary, on June 1-5, 2021.…
Maggie Little was part of the panel discussion around the Scientific and Ethical Considerations when Designing Clinical Trials that Enroll Pregnant People, which took place on February 2, 2021.…
Maggie Little and other researchers take a look at the way in which pregnant women and their offspring have been historically excluded from research agendas and investment strategies for vaccines against epidemic threats. They offer 22 concrete recommendations to ensure that the needs of pregnant women and their offspring are fairly addressed.…
Maggie Little chaired the Ethics of Research During Pregnancy discussion, that was part of the PHEPREN and Global Forum on Bioethics in Research (GFBR) seminar, which took place on November 30, 2020.…
In this event, hosted by the Georgetown University McDonough School of Business as part of the Stanton Distinguished Leader Series, Maggie Little moderated a conversation with Benevolent AI CEO Ken Mulvany on how AI is helping in the fight against COVID-19. The panelists discuss how business and technology are being used to help move us out of the COVID19 crisis.…
Maggie Little and her co-authors conducted 35 semi-structured interviews with reproductive-aged women in Malawi, in order to understand their views about participating in biomedical HIV prevention research during pregnancy. …
Maggie Little and her co-authors inquire on the views of women in the U.S. and in Malawi around the requirement of contraception among reproductive aged women in biomedical studies. They explore when such requirements are appropriate.…
Although pregnant women are highly susceptible to Plasmodium falciparum malaria, leading to substantial maternal, perinatal, and infant mortality, no trials of malaria vaccines have ever been conducted in pregnant women. This publication, co-authored by Maggie Little, resulted from the discussions held at an expert meeting convened in December 2016 at NIAID, NIH, in Rockville, Maryland to deliberate on the rationale and design of malaria vaccine trials in pregnant women.…